When we expressed shRNA directed against PGC1α in H1299 cells, the cell sensitivity to CDDP increased, suggesting that chemoresistance of lung cancer cells with low expression of p53 is associated with high levels of PGC1α. The gene discussed is PPARGC1A; the disease is lung carcinoma.